CORONA vs PARKHOSPS: Stock Comparison

Corona Remedies Ltd vs Park Medi World LtdUpdated 25 Aug 26, 4:08 PM ISTNSE & company filings

Corona Remedies Ltd is the larger company by market capitalisation. Corona Remedies Ltd shows a higher ROE, a higher dividend yield and a higher ROCE, while Park Medi World Ltd shows a lower P/E, lower leverage and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

CORONA leads 4; PARKHOSPS leads 7 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

CORONAPARKHOSPS

Valuation lens

What price are you paying?

Market CapContext only
₹12,843 Cr
₹12,282 Cr
P/E RatioPARKHOSPS has the lower reading
66.01x
46.91x
P/B RatioPARKHOSPS has the lower reading
17.59x
5.99x
EPSCORONA has the higher reading
₹30.3
₹5.98
Book ValueContext only
₹122
₹46.8
Dividend YieldCORONA has the higher reading
0.49%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
CORONA is the larger company
₹12,843 Cr vs ₹12,282 Cr
P/E Ratio
PARKHOSPS has a lower P/E
46.91x vs 66.01x
P/B Ratio
PARKHOSPS has a lower P/B
5.99x vs 17.59x
EPS
CORONA has higher earnings per share
₹30.3 vs ₹5.98
Dividend Yield
CORONA has a higher dividend yield
0.49% vs 0%
Qtr Sales Growth
PARKHOSPS has stronger quarterly sales growth
30.1% vs 20.2%
Qtr Profit Growth
PARKHOSPS has stronger quarterly profit growth
58% vs 43.7%
ROE
CORONA has a higher ROE
29.5% vs 16.7%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Price

MetricCORONAPARKHOSPS
Live Price₹2,097.3₹284.05
Day Change-2.41%1.43%
Volume14,1936.94 L
52-Week High₹2,270.1₹305
52-Week Low₹1,336.6₹138.1
Distance from 52W High-7.61%-6.87%

Valuation

MetricCORONAPARKHOSPS
Market Cap₹12,843 Cr₹12,282 Cr
P/E Ratio66.01x46.91x
P/B Ratio17.59x5.99x
EPS₹30.3₹5.98
Book Value₹122₹46.8
Dividend Yield0.49%0%

Growth

MetricCORONAPARKHOSPS
Revenue Growth (TTM YoY)0%0%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth20.2%30.1%
Qtr Profit Growth43.7%58%

Profitability & Leverage

MetricCORONAPARKHOSPS
ROE29.5%16.7%
ROCE33.3%19.3%
Net Margin13.19%16.29%
Operating Margin21%26.5%
Debt to Equity0.22x0.18x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricCORONAPARKHOSPS
Promoter Holding69%82.89%
FII Holding3.63% 1.38 pp0.82% 0.04 pp
DII Holding12.9% 5.88 pp8.95% 0.3 pp
Public Holding14.48% 7.26 pp7.33% 0.34 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Corona Remedies Ltd and Park Medi World Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.